SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-22-038101
Filing Date
2022-03-25
Accepted
2022-03-25 16:18:56
Documents
5
Period of Report
2022-04-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm223390-1_def14a.htm DEF 14A 614423
2 GRAPHIC lg_innoviva-bw.jpg GRAPHIC 13072
3 GRAPHIC sg_pavelraifeld-bw.jpg GRAPHIC 11626
4 GRAPHIC tm223390d1-px_01proxybw.jpg GRAPHIC 513093
5 GRAPHIC tm223390d1-px_02proxybw.jpg GRAPHIC 444066
  Complete submission text file 0001104659-22-038101.txt   1968316
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-30319 | Film No.: 22771665
SIC: 2834 Pharmaceutical Preparations